One shot for girls and a mail-in swab for women could hit the WHO 90-70-90 targets at a fraction of the cost of the traditional three-dose, clinic-based model.
KEN SHE showed 97.5% single-dose efficacy; self-sampled HPV PCR matches clinician sampling; thermal ablation enables screen-and-treat. Modelling (Lancet Global Health 2024) suggests single-dose schedules could make elimination feasible in most low-income settings within the century, but coverage of girls is still ~27% globally.
Shares KEN SHE (single-dose HPV vaccine), CERVAVAC (quadrivalent HPV vaccine, India), IARC India HPV vaccine dose study (one, two or three doses), Nonavalent HPV vaccine.
Shares CERVAVAC (quadrivalent HPV vaccine, India), Nonavalent HPV vaccine, Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination.
Shares Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17, Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed.
Shares Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17, Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed.
Shares Swedish registry study: HPV vaccination almost eliminates cervical cancer when given before 17, HPV DNA testing and self-sampling, HPV & HBV vaccination, Prevention we already have is not deployed.
Shares Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, HPV & HBV vaccination, Prevention we already have is not deployed, Most of the world has almost no cancer care.
Shares KEN SHE (single-dose HPV vaccine), Nonavalent HPV vaccine, HPV & HBV vaccination, Prevention we already have is not deployed.
Shares IARC India HPV vaccine dose study (one, two or three doses), HPV DNA testing and self-sampling, HPV & HBV vaccination, Cervical cancer.